30
Mar
2011
Immunicum holds a Scientific Advice Meeting
Immunicum holds a Scientific Advice Meeting with the Medical Products Agency to discuss the upcoming clinical phase I/II trial in renal cell carcinoma and considers the conditions for initiating the trial to be very favorable.